A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.
Also called NCT01117584
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 343 participants
- Sponsor
- Registry
-
NCT01117584 -
2009-013881-25
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Hungary, Italy, Poland, Romania, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01117584. Randomized; quadruple masking; primary purpose treatment. Start 2010-04-06 (actual); primary completion 2011-04-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
- Acronym
- BALANCE
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Metformin
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01117584- Content hash
53dd3cb967fcd6fe43767837a53ab5a3a5fc20d35143ae939c72839caf92460d